Star Lake Bioscience Co (SHSE:600866) Scaled Net Operating Assets : 0.78 (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Star Lake Bioscience Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Star Lake Bioscience Co's operating assets for the quarter that ended in Mar. 2024 was ¥13,632 Mil. Star Lake Bioscience Co's operating liabilities for the quarter that ended in Mar. 2024 was ¥2,456 Mil. Star Lake Bioscience Co's Total Assets for the quarter that ended in Dec. 2023 was ¥14,385 Mil. Therefore, Star Lake Bioscience Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.78.

Star Lake Bioscience Co Scaled Net Operating Assets Historical Data

The historical data trend for Star Lake Bioscience Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Lake Bioscience Co Scaled Net Operating Assets Chart

Star Lake Bioscience Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

1.11

0.87

4.25

0.63

0.65

Star Lake Bioscience Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.69	0.66	0.70	0.76	0.78

Competitive Comparison of Star Lake Bioscience Co's Scaled Net Operating Assets

For the Biotechnology subindustry, Star Lake Bioscience Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Star Lake Bioscience Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Star Lake Bioscience Co's Scaled Net Operating Assets falls into.

Star Lake Bioscience Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Star Lake Bioscience Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(12959.635	-	2514.402)	/	15999.51
=	0.65

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	14384.586	-	1424.951
=	12959.635

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	6725.179	-	1760.667	-	2450.11
=	2514.402

Star Lake Bioscience Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2024 )
=	(Operating Assets (Q: Mar. 2024 )	-	Operating Liabilities (Q: Mar. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(13632.438	-	2455.969)	/	14384.586
=	0.78

where

	Operating Assets		(Q: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	14687.215	-	1054.777
=	13632.438

	Operating Liabilities		(Q: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	6751.988	-	1705.445	-	2590.574
=	2455.969

Star Lake Bioscience Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Star Lake Bioscience Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Star Lake Bioscience Co (SHSE:600866) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » Scaled Net Operating Assets

Traded in Other Exchanges

N/A

Address

No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060

Website

http://www.starlake.com.cn

Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.

Star Lake Bioscience Co (SHSE:600866) Headlines

No Headlines